News

As the planet’s burden of rubber and plastic rises unabated, scientists look to the promise of closed-loop recycling to reduce trash. Researchers have discovered a potentially game-changing molecule, from a material used to make common products like tires and shoe soles, with vast implications for fulfilling that promise through depolymerization.

Evidence has shown that astrocytes can also actively promote neurodegeneration, inflammation, and neurological diseases. Now, a team has shown that a specific astrocyte sub-population can do the opposite, instead serving a protective, anti-inflammatory function based on signals regulated by the bacteria that reside in the gut.

A team has published the results of a study that evaluates the accuracy and bias in gender and skin colour of automatic face recognition algorithms tested with real world data.

Using machine learning, researchers at the UC Davis MIND Institute have identified several patterns of maternal autoantibodies highly associated with the diagnosis and severity of autism.

A study demonstrates, for the first time in humans, how the first deposits of tau proteins in the brainstem are associated with neurophysiological processes specific to the early stages of Alzheimer's disease development.

A new study demonstrates that antibodies generated by the novel coronavirus react to other strains of coronavirus and vice versa.

The US Food and Drug Administration (FDA) has approved the cardiovascular drug vericiguat. The drug is a once-daily oral treatment for patients with worsening chronic heart failure.

Break-induced replication (BIR) is a way to solve those problems. In humans, it is employed chiefly to repair breaks in DNA that cannot be fixed otherwise. A new study seeks to tease out BIR’s high risk-reward arrangement by describing for the first time the beginning-to-end sequence in BIR.

Coconut oil has increasingly found its way into kitchens in recent years, although its alleged health benefits are controversial. Scientists have now been able to show how it is metabolized in the liver. Their findings could also have implications for the treatment of certain diarrheal diseases.

Researchers have discovered that the chemotherapy drug doxorubicin is able to enter heart cells by hitchhiking on a specific type of protein that functions as a transporter to move drugs from the blood into heart cells. By introducing another anti-cancer drug in advance of the chemotherapy, the team was able to block the transporter protein.